AVH 0.81% $2.45 avita medical inc.

Ongoing clinical trials, page-3

  1. 412 Posts.
    lightbulb Created with Sketch. 26
    https://avitamedical.com/about-recell

    *In all countries outside of Europe, our portfolio is marketed under the RECELL® brand to promote skin healing in a wide range of applications including burns, chronic wounds and aesthetics. RECELL® is TGA-registered in Australia, CFDA-cleared in China and CE-mark in Europe. In the United States, RECELL® is not approved for sale and is limited by federal law to investigational use.


    NO UPDATE?!
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.